Literature DB >> 2161112

Intracerebroventricular injection of hemicholinium-3 prevents the ACTH-induced, but not the physostigmine-induced, reversal of hemorrhagic shock in rats.

S Guarini1, S Tagliavini, C Bazzani, F Ferrante, A Bertolini.   

Abstract

In rats bled to hypovolemic shock, the intracerebroventricular injection of hemicholinium-3 (20 micrograms/rat) completely prevented the shock reversal induced by the intravenous injection of ACTH (1-24) (160 micrograms/kg), but had no influence on the shock reversal induced by the intravenous injection of physostigmine (70 micrograms/kg). These data indicate that brain cholinergic neurons are involved in the anti-shock effect of ACTH-peptides, but not in that of centrally acting cholinergic drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161112     DOI: 10.1159/000138645

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  5 in total

1.  Brain M3 muscarinic receptors are involved in the ACTH-induced reversal of hemorrhagic shock.

Authors:  S Guarini; S Tagliavini; C Bazzani; M Pasini; A Bertolini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

2.  Choline administration reverses hypotension in spinal cord transected rats: the involvement of vasopressin.

Authors:  V Savci; I H Ulus
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

3.  Role of neuronal and vascular Ca(2+)-channels in the ACTH-induced reversal of haemorrhagic shock.

Authors:  S Guarini; C Bazzani; A Bertolini
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

4.  Reversal of experimental hemorrhagic shock by dimethylphenylpiperazinium (DMPP).

Authors:  S Guarini; C Bazzani; S Tagliavini; A Bertolini; W Ferrari
Journal:  Experientia       Date:  1992-07-15

5.  Nicotine reverses hemorrhagic shock in rats.

Authors:  S Guarini; S Tagliavini; C Bazzani; A Bertolini; W Ferrari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-04       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.